Skip to main content

Table 2 Characteristics of patients at microbial diagnosis

From: Comparative efficacy of linezolid and vancomycin for endotracheal tube MRSA biofilms from ICU patients

MRSA respiratory ICU infection (n = 25)

Linezolid (15)

Vancomycin (10)

p value

Respiratory infection

  

0.76

 Tracheobronchitis

2

2

 

 HAP

2

2

 

 VAP

8

5

 

 Early onset VAP

4

4

 

 Late onset VAP

4

1

 

 Severe CAP

3

1

 

Type of sample

  

0.24

 BAL

2

0

 

 BAS

10

10

 

 ETA

2

0

 

 Pleural fluid

1

0

 

Microbial diagnostic

   

 Log CFU/mL

6.0[4.0–6.0]

5.0[4.0–6.0]

0.40

 Polymicrobial respiratory infection

7

3

0.69

Radiographic consolidation

  

0.34

 None

2

0

 

 Monolateral

2

3

 

 Bilateral

11

7

 

Severity scores

 APACHE II ICU at microbial diagnosis

17.0[11.5–22.8]

17.5[6.5–22.3]

0.58

 SOFA ICU at microbial diagnosis

8.0[1.8–10.0]

7.0[5.5–10.8]

0.55

  1. Data are presented as median and interquartile range [percentiles 25th–75th] or n (%). ICU intensive care unit, HAP hospital-acquired pneumonia, VAP ventilator-associated pneumonia, CAP community-acquired pneumonia, BAL bronchoalveolar lavage, BAS tracheobronchial aspirates, ETA endotracheal aspirates, APACHE II Acute Physiology and Chronic Health Evaluation, SOFA Sequential Organ Failure Assessment, MRSA methicillin-resistant S. aureus, CFU colony-forming units
Back to article page

Critical Care

ISSN: 1364-8535